Category: Volcano Corp.
Shares of Volcano Corp. are up this morning after the medical device company launches a stock buyback worth up to $200 million.
A stock buyback worth up to $200 million sent shares of Volcano (NSDQ:VOLC) up nearly 6% this morning.
Analyst say that diagnostics maker Volcano is looking more and more like an attractive target for the likes of Medtronic or Abbott Labs.
MASSDEVICE ON CALL — Diagnostics and stents maker Volcano (NSDQ:VOLC) may be primed for acquisition, with a raft of analysts' groups debating only the timing of a buy.
Engaged Capital, an investment fund founded by Glenn Welling, reveals a 5.1% stake in Volcano Corp. and demands changes to management compensation pay, a $200 million in share buyback program and more focus on organic growth.
Company officials at Volcano (NSDQ:VOLC) are keeping quiet about an aggressive stock purchase from activist investor Glenn Welling and his fund, Engaged Capital.
Company officials at Volcano Corp. discuss the company's Q3 2013 results. Volcano reported an $8.5 million loss on $95.8 million in sales for the 3-month period ended Sept. 30.
Volcano Corp. shares plunge in pre-market trading after the medical device company cuts its sales forecast for the rest of 2013.
Investors slashed some 18% from Volcano (NSDQ:VOLC) shares this morning after the medical device company cut its sales outlook for 2013, blaming lower stenting procedure volumes and slower-than-expected sales of its fractional flow reserve devices in Japan.
The U.S. Patent & Trademark Office declines to review a patent in St. Jude Medical's long-running war with rival Volcano Corp.
Volcano Corp. acquires Medtronic's Pioneer Plus re-entry catheters in a closed-doors deal expected to land this month.